Strong Results Boosted Guardant Health (GH) in Q2
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. U.S.
Guardant Health Inc. (GH)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Walleye Capital Will England | 104,527 | $15,682,186 | -65% | 0.06% |
| 2. | 1,175,000 | $1,463,709 | -7% | 0.06% | |
| 3. | Sciencast Management Qing Li | 7,124 | $1,068,814 | 0.22% | |
| 4. | RiverPark Advisors Mitch Rubin | 2,754 | $413,183 | +510% | 0.19% |
| 5. | 1,900 | $285,057 | -69% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $130.76 | 600 | $78,456.00 | 41,414 | 2026-06-15 | Filing | |
| $17.82 | 2,187 | $38,962.72 | 12,722 | 2024-03-18 | Filing | |
| $32.78 | 750 | $24,584.25 | 5,193 | 2023-06-09 | Filing | |
| $32.68 | 2,231 | $72,913.77 | 4,443 | 2023-06-09 | Filing | |
| $26.15 | 8,600 | $224,927.84 | 2,049,238 | 2023-03-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $163.29 | 116 | $18,941.64 | 11,182 | 2026-07-16 | Filing | |
| $131.08 | 600 | $78,648.00 | 40,814 | 2026-06-15 | Filing | |
| $130.86 | 600 | $78,516.00 | 40,814 | 2026-06-10 | Filing | |
| $153.00 | 40 | $6,120.00 | 1,881,336 | 2026-06-29 | Filing | |
| $152.20 | 46,663 | $7,102,318.58 | 1,881,376 | 2026-06-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 577,313 | $88,756,101 | 0.69% | |
| 2. | 404,816 | $60,734,544 | 0.03% | |
| 3. | 356,001 | $53,410,829 | 0.03% | |
| 4. | 274,052 | $41,116,022 | 0.01% | |
| 5. | 272,671 | $40,908,830 | 0.05% |
News See All
10 Best Large Cap Stocks to Buy Under $100
On May 13, Sarat Sethi, DCLA Managing Partner, joined 'The Exchange' on CNBC to discuss a notable shift in market sentiment and the emerging opportunities in the software sector.
10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen
On April 30, Bloomberg reported that Steve Cohen resigned as president of Point72 Asset Management, and Harry Schwefel was appointed co-CIO.
Guardant Health, Inc. (NASDAQ:GH) Q1 2026 Earnings Call Transcript
Operator: Good afternoon. Thank you for attending the Guardant Health Q1 2026 Earnings Call. My name is Matt, and I'll be the moderator for today's call.
Does Guardant Health (GH) Have Long-Runway for Growth?
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Guardant Health (GH) and Verana Health Announces New Partnership
Guardant Health, Inc. (NASDAQ:GH) is one of the best high growth healthcare stocks to buy now. Guardant Health, Inc.
11 High Growth Healthcare Stocks to Buy Now
On March 26, Stephanie Link, Hightower chief investment strategist, appeared on CNBC's ‘Squawk Box’ to talk about the latest market trends, where investors can find opportunities, and the effects ...
15 Most Promising Stocks Under $100 to Buy
On March 12, Roger Ferguson, former Fed Vice Chair, joined 'Closing Bell' on CNBC to discuss what to expect from the Federal Reserve next week.
Why Guardant Health’s (GH) 2026 Screening Story Reinforced Piper Sandler’s Bullish View
As of March 13, 2026, Guardant Health carried a Moderate Buy consensus from 23 analysts, based on 21 Buy ratings, one Hold, and one Sell.
11 Best Growth Stocks to Invest in According to Billionaires
Infotech and biotech remain two of the clearer growth pockets because the underlying spending data is still expanding.
Hedge Fund Resource Center